ANG Lifesciences India Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials. It operates in two segments, namely pharmaceuticals and printing and packaging. The Company's product portfolio includes various products comprising therapeutic categories, such as Antibiotics, Antiviral, Antimalarial, Antiulcer, Carbapenem, Corticosteroid, Penicillin and Beta Lactamase Inhibitor. The Company’s product category includes Dry Powder Injection, Liquid Injections, Hard Gelatin Capsule, Tablet Beta Lactum, Tablets, Liquid Suspension /Syrup, Ointment/Creams, and Soft Gelatin Capsule. Its Dry Powder Injection products include Ampicillin & Cloxacillin for injection 500mg, Azetronam for Injection USP 500mg, Ampicillin Injection 1.0gm, Ceftriaxone Injection 250mg, Amoxycillin & Potassium Clavulanate for injection 1.2gm, and others. As of 14 Jun 2026, ANG Lifesciences India Limited share price is ₹30.90. The stock opened at ₹29.90, compared to its previous close of ₹29.92. During today's trading session, ANG Lifesciences India Limited share price moved in the range of ₹29.51 to ₹31.10, with an average price of ₹30.30 for the day. Looking at its last 52-week, the stock has touched a low of ₹29.51 and a high of ₹31.10.
The market capitalization of ANG Lifesciences India Limited is ₹40 Crs, with a P/E ratio of -3.6 and a dividend yield of 0.00%.